Mehdi Alem, Sara Nejjari, Mounir Belcadi Abbassi, Maryam Msakem, Diango Keita, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi & Nawfel Mellas·International Research Journal of Oncology·2026
Background: Epithelioid angiosarcoma (EAS) is a rare, high-grade vascular malignancy with epithelioid morphology and considerable diagnostic overlap with poorly differentiated carcinoma. Primary spinal involvement is exceptionally uncommon, and metastatic disease at presentation...
Open access
Research Article10.9734/irjo/2026/v9i2220
Background: Persistent infection with high-risk human papillomavirus (hr-HPV) is associated with cervical epithelial abnormalities and may progress to invasive cervical cancer when not detected and managed appropriately. This study determined the prevalence and patterns of hr-HPV...
Open access
Research Article10.9734/irjo/2026/v9i2219
Background: Previous prostate cancer research has often been conducted in clinical or laboratory settings and has relied on traditional survival models that focus on a single disease endpoint. Such approaches do not fully account for intermediate disease states, transition risks,...
Open access
Research Article10.9734/irjo/2026/v9i2218
Joy Taiye Babalola, Okeoghene Marcel Edafetanure-Ibeh, Quadri O. Adewuyi, Favour Chibuzor, Sonay Unsal, Monsuru Olarewaju Moshood, Michael Kyere & Oluwadunsin Rachael Ajayi·International Research Journal of Oncology·2026
Cancer remains a major global health challenge, creating a continuing need for safer, effective and sustainable therapeutic discovery. Plant-derived phytochemicals have contributed substantially to oncology drug development, and many clinically used anticancer agents originate di...
Open access
Research Article10.9734/irjo/2026/v9i2217
Background: Urban-rural differences in ovarian cancer remain insufficiently described in Central Asia, and evidence from Uzbekistan is limited. This study assessed national trends and interregional differences in registered ovarian cancer incidence by type of residence in Uzbekis...
Open access
Research Article10.9734/irjo/2026/v9i2216
Background: The Gleason grading system is the gold standard for assessing prostate cancer aggressiveness. Whether serum Prostate Specific Antigen (PSA) and testosterone can predict histological grade remains debated, with limited data from West African populations. Aim: The study...
Open access
Research Article10.9734/irjo/2026/v9i2215
Mehdi Alem, Sara Nejjari, Assiya Benamar, Mounir Belcadi Abbassi, Maryam Msakem, Diango Keita, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi, Touria Bouhafa & Nawfel Mellas·International Research Journal of Oncology·2026
Background: Malignant glomus tumors are rare neoplasms, and vulvar involvement is exceptionally uncommon, creating significant diagnostic challenges. Aims: This case study reports an exceptional case of malignant glomus tumor of the vulva presenting with small round cell morpholo...
Open access
Research Article10.9734/irjo/2026/v9i2214
Mehdi Alem, Sara Nejjari, Assiya Benamar, Mounir Belcadi Abbassi, Maryam Msakem, Diango Keita, Lamiae Amaadour, Karima Oualla, Zineb Benbrahim, Samia Arifi, Touria Bouhafa & Nawfel Mellas·International Research Journal of Oncology·2026
Background: Ewing's sarcoma (ES) arising from the pleura is an exceedingly rare entity, accounting for fewer than 2% of all ES cases. Its rarity and non-specific clinical presentation frequently result in diagnostic delays and therapeutic challenges. Presentation of Cases: We rep...
Open access
Research Article10.9734/irjo/2026/v9i2211
Oral cancer remains a critical global health challenge, with rising trends, particularly in South and Southeast Asia. In Myanmar, the disease represents a significant public health crisis, consistently ranking among the top ten causes of morbidity and mortality. Epidemiological d...
Open access
Research Article10.9734/irjo/2026/v9i2212
Isabela Sacco Camara, Aline Pelosini Gomes, Olívia Voelzke Passarin, Amanda Scaff Mendes, Kalil Sallum Haddad Dib & Juliano dos Santos·International Research Journal of Oncology·2026
Background: Glioblastoma is an aggressive primary brain tumour with poor survival outcomes, where distinguishing true tumour recurrence from treatment-related pseudoprogression on post-therapy MRI remains a major clinical challenge. Aims: The primary objective of this study was t...
Open access
Research Article10.9734/irjo/2026/v9i2213